Increase in excitatory amino acid concentration and transporters expression in osteoarthritic knees of anterior cruciate ligament transected rabbits

Osteoarthritis and Cartilage

Volumn 16, Issue 12, 2008, Pages 1442-1449

  Jean, Y H ^a   Wen, Z H ^b   Chang, Y C ^b   Hsieh, S P ^a   Lin, J D ^c   Tang, C C ^d   Chen, W F ^e   Chou, A K ^e   Wong, C S ^f  

^a PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d NATIONAL PINGTUNG UNIVERSITY   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Anterior cruciate ligament; Excitatory amino acid transporters; Glutamate; Glutamate transporters; Microdialysis; Osteoarthritis

Indexed keywords

ASPARTIC ACID; EXCITATORY AMINO ACID; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CRUCIATE LIGAMENT RUPTURE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; DIALYSATE LEVEL; DISEASE SEVERITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; JOINT CAVITY; KNEE OSTEOARTHRITIS; MALE; MICRODIALYSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; WESTERN BLOTTING;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; ASPARTIC ACID; CLINICAL PROTOCOLS; EXCITATORY AMINO ACIDS; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; MEMBRANE TRANSPORT PROTEINS; MICRODIALYSIS; OSTEOARTHRITIS, KNEE; RABBITS; RANGE OF MOTION, ARTICULAR;

EID: 54149117749     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.04.008     Document Type: Article

References (47)

1. Moralestorres J., Reginister J.C., and Hochberg M.C. Rheumatic and musculoskeletal disease and impaired quality of life: a challenge for rheumatologists. J Rheumatol 23 (1996) 1-3
2. Myers S.L., Brandt K.D., Ehlich J.W., Braunstein E.M., Shelbourne K.D., Heck D.A., et al. Synovial inflammation in patients with early osteoarthritis of the knee. J Rheumatol 17 (1990) 1662-1669
3. Pelletier J.P., Martel-Pelletier J., and Abramson S.B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 44 (2001) 1237-1247
4. Sommerlath K., Lysholm J., and Gillquist N. The long-term course after treatment of acute anterior cruciate ligament rupture. A 9 to 16 year follow up. Am J Sports Med 19 (1991) 156-162
5. Daniel D.M., Stone M., Dobson B.E., Fithian D.C., Rossman D.J., and Kaufman K.R. Fate of the ACL-injured patient. Am J Sports Med 22 (1994) 632-644
6. Danbolt N.C. Glutamate uptake. Prog Neurobiol 65 (2001) 1-105
7. Chenu C., Serre C.M., Raynal C., Burt-Pichat B., and Delmas P.D. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone 22 (1998) 295-299
8. Patton A.J., Genever P.G., Birth M.A., Suva L.J., and Skerry T.M. Expression of an NMDA type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone 2 (1998) 645-649
9. Spencer G.J., McGrath C.J., and Genever P.G. Current perspectives on NMDA-type glutamate signalling in bone. Int J Biochem Cell Biol 39 (2007) 1089-1104
10. Westlund K.N., Sun Y.C., Sluka K.A., Dougherty P.M., Sorkin L.S., and Willis W.D. Neural changes in acute arthritis in monkeys. II. Increased glutamate immunoreactivity in the medial articular nerve. Brain Res Rev 17 (1992) 15-27
11. McNearney T., Speegle D., Lawand N., Lisse J., and Westlund K.N. Excitatory amino acid profiles of synovial fluid derived from patients with arthritis. J Rheumatol 27 (2000) 739-745
12. Lawand N.B., McNearney T., and Westlund K. Amino acid release into the knee joint: key role in nociception and inflammation. Pain 86 (2000) 69-74
13. Jean Y.H., Wen Z.H., Chang Y.I., Huang G.S., Lee H.S., Hsieh S.P., et al. Increased concentrations of neuro-excitatory amino acids in rat anterior cruciate ligament-transected knee joint dialysates: a microdialysis study. J Orthop Res 23 (2005) 569-575
14. Hinoi E., Takarada T., and Yoneda Y. Glutamate signaling system in bone. J Pharmacol Sci 94 (2004) 215-220
15. Mason D.J., Suva L.J., Genever P.G., Patton A.J., Steuckle S., Hillam R.A., et al. Mechanical regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents. Bone 20 (1997) 199-205
16. Stoop R., Buma P., van der Kraan P.M., Hollander A.P., Billinghurst R.C., Meijers T.H.M., et al. Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats. Osteoarthritis Cartilage 9 (2001) 308-315
17. Jean Y.H., Wen Z.H., Chang Y.C., Hsieh S.P., Tang C.C., Wang Y.H., et al. Intra-articular injection of the cyclooxygenase-2 inhibitor parecoxib attenuates osteoarthritis progression in anterior cruciate ligament-transected knee in rats: role of excitatory amino acids. Osteoarthritis Cartilage 15 (2007) 638-645
18. Wen Z.H., Yang L.C., Wang J.J., Chang Y.C., Hsing C.H., Chen J.Y., et al. Intrathecal pertussis toxin induces thermal hyperalgesia: involvement of excitatory and inhibitory amino acids. Neuroscience 116 3 (2003) 871-878
19. Fernandes J.C., Martel-Pelletier J., Otterness I.G., Lopez-Anaya A., Mineau F., and Tardif G. Effects of tenidap on canine experimental osteoarthritis. I. Morphologic and metalloprotease analysis. Arthritis Rheum 38 9 (1995) 1290-1303
20. Pelletier J.P., Jovanovic D., Fernades J.C., Manning P., Connor J.R., Currie M.G., et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 41 (1998) 1275-1286
21. Mankin H.J., Dorfman H., Lippiello L., and Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg 53A (1971) 523-537
22. Yoshimi T., Kikuchi T., Obrara T., Yamaguchi T., Sakakibara Y., Itoh H., et al. Effects of high-molecular-weight sodium hyaluronate on experimental osteoarthritis induced by the resection of rabbit cruciate ligament. Clin Orthop Relat Res 298 (1994) 296-304
23. Pelletier J.P., Mineau F., Faure M.P., and Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum 33 (1990) 1466-1476
24. Goldenberg D.L., Egan M.S., and Cohen A.S. Inflammatory synovitis in degenerative joint disease. J Rheumatol 9 (1982) 204-209
25. Lawand N.B., Willis W.D., and Westlund K.N. Excitatory amino acid receptor and involvement in peripheral nociceptive transmission in rats. Eur J Pharmacol 324 (1997) 169-177
26. Bhangu P.S., Genever P.G., Spencer G.J., Grewal T.S., and Skerry T.M. Evidence for targeted vesicular glutamate exocytosis in osteoblasts. Bone 29 (2001) 16-23
27. Skerry T.M., and Genever P.G. Glutamate signaling in non-neuronal tissues. Trends Pharmacol Sci 22 (2001) 174-181
28. deGroot J.F., Zhou S., and Carlton S.M. Peripheral glutamate release in the hindpaw following low and high density sciatic stimulation. Neuroreport 11 (2000) 497-502
29. Flood S., Parri R., Williams A., Duance V., and Mason D. Modulation of interleukin-6 and matrix metalloproteinase 2 expression in human fibroblast-like synoviocytes by functional ionotropic glutamate receptors. Arthritis Rheum 56 (2007) 2523-2534
30. Parada-Turska J., Rzeski W., Majdan M., Kandefer-Szerszen M., and Turski W.A. Effect of glutamate receptor antagonists and antirheumatic drugs on proliferation of synoviocytes in vitro. Eur J Pharmacol 535 (2006) 95-97
31. Zerangue N., and Kavanaugh M.P. Flux coupling in a neuronal glutamate transporter. Nature 383 (1996) 634-637
32. Genever P.G., and Skerry T.M. Regulation of spontaneous glutamate release activity in osteoblastic cells and its role in differentiation and survival: evidence for intrinsic glutamatergic signaling in bone. FASEB J 15 (2001) 1586-1588
33. Hinoi E., Wang L., Takemori A., and Yoneda Y. Functional expression of particular isoforms of excitatory amino acid transporters by rodent cartilage. Biochem Pharmacol 70 (2005) 70-81
34. Sung B., Lim G., and Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 23 7 (2003) 2899-2910
35. Wu G.J., Chen W.F., Sung C.S., Jean Y.H., Shih C.M., Shyu C.Y., et al. Preventive effects of intrathecal methylprednisolone administration on spinal cord ischemia in rats: the role of excitatory amino acid metabolizing systems. Neuroscience 147 2 (2007) 294-303
36. Sattler R., and Rothstein J.D. Regulation and dysregulation of glutamate transporters. Handb Exp Pharmacol 175 (2006) 277-303
37. Danbolt N.C., Pines G., and Kanner B.I. Purification and reconstitution of the sodium- and potassium-coupled glutamate transport glycoprotein from rat brain. Biochemistry 29 (1990) 6734-6740
38. Raunser S., Haase W., Bostina M., Parcej D.N., and Kühlbrandt W. High-yield expression, reconstitution and structure of the recombinant, fully functional glutamate transporter GLT-1 from Rattus norvegicus. J Mol Biol 351 (2005) 598-613
39. Conradt M., Storck T., and Stoffel W. Localization of N-glycosylation sites and functional role of the carbohydrate units of GLAST-1, a cloned rat brain l-glutamate/l-aspartate transporter. Eur J Biochem 229 (1995) 682-687
40. Huggett J.F., Vaughan-Thomas A., and Mason D.J. The open reading frame of the Na(+)-dependent glutamate transporter GLAST-1 is expressed in bone and a splice variant of this molecule is expressed in bone and brain. FEBS Lett 485 (2000) 13-18
41. Vallejo-Illarramendi A., Domercq M., and Matute C. A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptake is negative regulator of glutamate uptake. J Neurochem 95 (2005) 341-348
42. Macnab L.T., and Pow D.V. Expression of the exon 9-skipping form of EAAT2 in astrocytes of rats. Neuroscience 150 (2007) 705-711
43. Lin C.L., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., et al. Aberrant RNA processing in a neurodegenerative disease: the cause of absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20 (1998) 589-602
44. Meyer T., Munch C., Knappenberger B., Liebau S., Volkel H., and Ludolph A.C. Alternative splicing of glutamate transporter EAAT2 (GLT-1). Neurosci Lett 241 (1998) 68-70
45. Meyer T., Fromm A., Munch C., Schwalenstocker B., Fray A.E., Ince P.G., et al. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals. J Neurol Sci 170 (1999) 45-50
46. Huggett J.F., Mustafa A., O'Neal L., and Mason D.J. The glutamate transporter GLAST-1 (EAAT-1) is expressed in the plasma membrane of osteocytes and is responsive to extracellular glutamate concentration. Biochem Soc Trans 30 6 (2002) 890-893
47. Hinoi E., Ohashi R., Miyata S., Kato Y., Iemata M., Hojo H., et al. Excitatory amino acid transporters expressed by synovial fibroblasts in rats with collagen-induced arthritis. Biochem Pharmacol 70 12 (2005) 1744-1755